Exact Sciences stock holds as Nasdaq reaches a record high

Published on 09/23/2026 at 12:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Exact Sciences stock traded during a September 23, 2026 market session shaped by a 0.45 percent Nasdaq gain. The latest company figures remain period based.

Schwarz-Weiß-Reportage einer Pathologin am Mikroskop im Diagnostiklabor von Exact Sciences — Exact Sciences Corp. zeigt den diagnostischen Laboralltag in einer eindrucksvollen Schwarzweiß Reportagefotografie US30063P1057, Illustration mit AI erstellt.

Exact Sciences stock traded against a Nasdaq Composite gain of 0.45 percent on September 23, 2026, when the index reached 27,243.24 points at the prior session close. The company remains identified by ISIN US30063P1057 and trades on Nasdaq under the ticker EXAS.

Nasdaq strength sets the backdrop

The broader US technology market provided a quantified reference point for Exact Sciences on September 23, 2026. The Nasdaq Composite added 121.15 points, rising from 27,122.09 to 27,243.24 points, according to market coverage published by The Economic Times on September 23, 2026.

That index move matters because it defines the immediate trading backdrop for growth-oriented healthcare and diagnostics shares, but it does not by itself establish a company-specific catalyst. For Exact Sciences, the more durable valuation reference remains the latest reported operating period and the next verified corporate update.

Reported figures remain the anchor

Exact Sciences is a molecular diagnostics company whose stock story depends on screening adoption, test volume, reimbursement and operating leverage. The available current market coverage does not provide a period-specific Exact Sciences revenue, earnings, margin or guidance figure that can be safely presented as a newly reported result on September 23, 2026.

The distinction is important for investors: a market index figure dated September 23, 2026 is a current trading measure, while a company fundamental must be tied to a named quarter, half-year or fiscal year. The article therefore separates the dated Nasdaq benchmark from company operating claims and avoids assigning an undated figure to the current reporting cycle.

Exact Sciences stock stays tied to Nasdaq

Exact Sciences stock remains a Nasdaq-listed US security with the primary trading currency USD. The company identity is fixed by ISIN US30063P1057 and ticker EXAS, while the September 23, 2026 market backdrop was defined by a Nasdaq Composite level of 27,243.24 points and a daily increase of 0.45 percent.

The quantified comparison is the index change itself: Nasdaq gained 121.15 points, or 0.45 percent, versus its previous close on September 23, 2026. That benchmark gives the stock a dated reference without treating broad-market strength as proof of a company-specific earnings surprise or analyst revision.

Market backdrop remains measurable

On September 23, 2026, the Nasdaq Composite closed at 27,243.24 points after gaining 121.15 points, equal to 0.45 percent. Exact Sciences stock is therefore being assessed within a clearly dated US equity setting, while company-level revenue, earnings and guidance remain period dependent.